What is GKB Ophthalmics Ltd (GKB) share price return in the past 10 years?

GKB Ophthalmics Ltd share price has declined -7% annually (CAGR) over the past ten years.

What is the share price of GKB Ophthalmics Ltd (GKB)?

Company share prices are keep on changing according to the market conditions. The current trading price of GKB Ophthalmics Ltd (GKB) on 29-Sep-2026 16:59:59 at 16:59 is 64.07.

What is the P/E ratio of GKB Ophthalmics?

The latest standalone P/E ratio of GKB Ophthalmics as of 29-Sep-2026 is 0.00.

What is the P/B ratio of GKB Ophthalmics Ltd (GKB)?

The latest standalone P/B ratio of GKB Ophthalmics Ltd (GKB) as of 29-Sep-2026 is 2.34.

What is the 52-week high and low of GKB Ophthalmics Ltd (GKB)?

The 52-week high of GKB Ophthalmics Ltd (GKB) is Rs. 76.90 and the 52-week low is Rs. 45.25.

GKB Ophthalmics Ltd (GKB)

Name: GKB Ophthalmics Ltd (GKB)
Brand: GKB Ophthalmics

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533212 NSE: GKB Medical Equipment/Supplies/Accessories | Small Cap | GKB Ophthalmics Share Price

₹64.07 -0.93 (-1.43%)

As on 29-Sep'26 16:59

GKB Ophthalmics Ltd (GKB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533212 NSE: GKB Medical Equipment/Supplies/Accessories | Small Cap | GKB Ophthalmics Share Price

₹64.07 -0.93 (-1.43%)

As on 29-Sep'26 16:59

Key Metrics

Valuation Multiples

Market Cap

₹32 Cr.

Current Price

₹64.1

52-Week Low / High

₹45 / 77

TTM EPS

₹6.4

TTM Sales

₹150 Cr.

Book Value per Share

₹108.6

P/E Ratio

9.96

Industry PE

126.3

Price to Book (P/B)

0.59

Lower than its 5-year historical median

Price to Sales (P/S)

0.22

Lower than its 5-year historical median

EV/EBITDA

3.01

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

5.77%

Underperforms industry median

Return on Capital Employed (ROCE)

8.82%

Underperforms industry median

Return on Assets (ROA)

2.28%

Operating Profit Margin

5.8%

Net Profit Margin

2.03%

Gross Profit Margin

5.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-21.71%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

51.15%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹50 Cr.

Equity

₹5 Cr.

Face Value

₹10

All Time Low / High

₹12.25 / 209.20

GKB Ophthalmics stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is GKB Ophthalmics Ltd a good quality company?

GKB Ophthalmics Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does GKB Ophthalmics Ltd performance compare with that of its Peers?

Q.1 Revenue growth of GKB Ophthalmics Ltd vs industry peers?

GKB Ophthalmics Ltd revenue CAGR is 21.25%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of GKB Ophthalmics Ltd?

Promoters hold 51.15% of the GKB Ophthalmics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of GKB Ophthalmics Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -5.9% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	6.5%	-4.1%	-4.6%	-6.3%	-2.1%	-2.2%	-3.8%	-4.8%	-11.7%	-4.9%	-
Value Creation Index ⓘ	-0.5	-1.3	-1.3	-1.5	-1.2	-1.2	-1.3	-1.4	-1.8	-1.4	-
Growth Parameters ⓘ
Sales ⓘ	38.3	36.9	30.5	25.6	21.3	27.1	27.7	31.2	32.8	25.6	23
Sales YoY Gr.	-	-3.7%	-17.5%	-16.1%	-16.5%	26.8%	2.5%	12.4%	5%	-21.7%	-
Adj EPS ⓘ	-3.4	-6.4	-8.1	-8.5	-2.9	-4.7	-5.9	-7	-12.1	-6.3	-3.8
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	71.2	64.9	68.5	69.9	65	60.3	54.6	47.6	35.1	28.4	27.4
Adj Net Profit ⓘ	-1.4	-2.7	-3.8	-4.3	-1.5	-2.4	-3	-3.5	-6.1	-3.2	-2
Cash Flow from Ops. ⓘ	-4.2	-3.7	5.3	6.1	2.1	2.3	-1.1	1.4	-5	-1.5	-
Debt/CF from Ops. ⓘ	-1.7	-2.7	1.9	1.6	5.7	5	-9.8	8.1	-3.6	-6.4	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-4.4%	3.7%	-2.6%	-21.7%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	-9.7%	-15.3%	-19.6%	-18.9%
Share Price	-7%	-6.7%	-14.1%	-4.8%

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	-4.9	-9.4	-12.2	-12.3	-4.3	-7.4	-10.3	-13.6	-29.4	-19.8	-13.7
Op. Profit Mgn % ⓘ	-1.1	-2.7	-3.3	-2.9	-1.3	-1.5	-4	-4.1	-10.6	-11.6	-11.5
Net Profit Mgn % ⓘ	-3.7	-7.2	-12.3	-16.8	-6.9	-8.7	-10.8	-11.2	-18.7	-12.4	-8.3
Debt to Equity ⓘ	0.2	0.4	0.3	0.3	0.4	0.4	0.4	0.5	1	0.7	-
Working Cap Days ⓘ	236	275	328	355	383	287	258	230	234	312	109
Cash Conv. Cycle ⓘ	148	182	190	128	144	90	78	64	72	96	-49

Valuation of GKB Ophthalmics - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	74.08	77.42	57.16	58.53	56.88	70.94	75.47	88.25	108.99	149.06
Operating Expenses ⓘ +	72.25	76.08	56.02	56.40	54.96	66.09	71.79	87.67	111.77	140.44
Manufacturing Costs	10.39	10.57	6.12	5.56	5.05	5.54	6.74	5.78	5.86	5.22
Material Costs	50.01	52.16	35.57	37.10	37.06	44.85	47.40	59.74	73.45	105.40
Employee Cost	8.62	8.98	9.27	8.10	7.86	9.49	11.15	13.76	17.26	16.11
Other Costs ⓘ	3.23	4.36	5.06	5.63	4.99	6.20	6.49	8.40	15.20	13.72
Operating Profit ⓘ	1.83	1.34	1.14	2.14	1.92	4.85	3.69	0.58	-2.78	8.62
Operating Profit Margin (%)	2.5%	1.7%	2.0%	3.7%	3.4%	6.8%	4.9%	0.7%	-2.6%	5.8%
Other Income ⓘ +	1.30	0.49	2.18	0.50	2.43	1.15	0.92	1.51	1.33	2.24
Exceptional Items ⓘ	2.53	0	0	0	-0.72	0	0	0	0	-1.79
Interest ⓘ	1.29	1.27	1.48	1.46	2.03	1.48	1.67	1.90	2.37	2.67
Depreciation ⓘ	1.43	1.70	3.54	3.62	3.14	2.67	2.83	2.90	3.09	3.24
Profit Before Tax ⓘ	2.94	-1.14	-1.70	-2.45	-0.93	1.95	0.14	-2.78	-6.73	3.10
Tax ⓘ	0.36	-0.17	-0.48	0	-0.18	0	0.02	0.21	0.35	0.08
Profit After Tax	2.59	-0.97	-1.22	-2.45	-0.75	1.94	0.12	-2.98	-7.08	3.03
PAT Margin (%)	3.5%	-1.3%	-2.1%	-4.2%	-1.3%	2.7%	0.2%	-3.4%	-6.5%	2.0%
Adjusted EPS (₹)	6.2	-2.3	-2.4	-3.7	-1.8	2.5	-0.3	-5.6	-14.0	2.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	46.79	44.94	51.90	59.25	62.65	63.10	62.69	59.77	52.04	52.83
Share Capital ⓘ	4.15	4.15	4.64	5.04	5.04	5.04	5.04	5.04	5.04	5.04
Reserves ⓘ	42.63	40.79	47.26	54.21	57.61	58.06	57.65	54.73	47	47.79
Debt +	7.12	9.88	14.05	15.12	11.32	11.24	10.82	11.04	12.56	8.76
Long Term Debt	0.07	0.02	0	0	1	1.62	1.17	1.05	3.08	1.57
Short Term Debt	7.05	9.86	14.05	15.12	10.32	9.62	9.65	9.99	9.48	7.19
Minority Interest	0	0	0	0	3.65	4.32	4.6	4.43	4.4	2.05
Trade Payables	23.18	24.03	21.18	23.77	23.78	25.57	23.79	33.09	39.29	56.29
Others Liabilities ⓘ	8.43	4.13	10.04	7.85	9.15	9.68	13.92	9.90	20.86	16.15
Total Liabilities ⓘ	85.51	82.98	97.17	105.99	110.56	113.90	115.82	118.24	129.14	136.09
Fixed Assets
Net Fixed Assets ⓘ +	17.60	18.34	25.85	26.33	23.75	22.65	19.04	18.22	17.03	15.01
Gross Block	35.64	37.54	48.41	52.62	45.78	46.77	46.03	48.03	48.90	50.31
Accumulated Depreciation	18.03	19.20	22.56	26.29	22.02	24.12	27	29.82	31.87	35.30
CWIP ⓘ	0.57	0.24	0	0	1.23	3.41	3.95	3.91	3.91	3.78
Investments ⓘ	3.48	0.37	0.54	1.15	2.08	1.97	1.89	1.83	2.01	1.95
Inventories	30.83	32.01	27.73	30.42	35.41	37.70	38.74	40.02	50.38	54.63
Trade Receivables	24.72	27.46	23.54	24.92	19.48	19.51	27.74	28.40	25.49	44.87
Cash Equivalents	2.84	2.55	10.04	13.87	17.28	16.40	14.45	17.84	13.82	4.90
Others Assets ⓘ	5.46	2.01	9.46	9.30	11.32	12.25	10.02	8.03	16.50	10.95
Total Assets ⓘ	85.51	82.98	97.17	105.99	110.56	113.90	115.82	118.24	129.14	136.09

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	-3.41	-2.66	3.92	3.27	6.86	5.07	-2.77	4.22	-3.43	-3.81
PBT ⓘ	2.94	-1.14	-1.58	-1.84	-0.93	1.95	0.14	-2.78	-6.73	3.10
Adjustment ⓘ	0.25	3.67	3.96	4.95	3.30	3.52	3.89	3.90	9.36	4.70
Changes in Working Capital ⓘ	-5.29	-5.08	1.56	0.17	4.52	-0.32	-6.64	3.28	-5.93	-11.27
Tax Paid ⓘ	-1.30	-0.12	-0.03	-0.01	-0.04	-0.08	-0.16	-0.19	-0.14	-0.34
Cash Flow From Investing Activity ⓘ +	3.75	1.34	-9.89	-3.73	-16.78	-3.52	1.43	-1.71	2.55	9
Capex	-5.98	-1.86	-9.97	-3.75	-5.99	-4.63	0.99	-2.03	-2.11	-0.90
Net Investments	9.38	3.11	-0.06	-0	-10.81	0.98	-1.63	-2.51	3.76	8.55
Others ⓘ	0.34	0.09	0.13	0.02	0.03	0.12	2.07	2.83	0.90	1.35
Cash Flow From Financing Activity ⓘ +	-1.33	1.37	13.13	4.30	2.77	-1.66	-2.19	-1.64	0.67	-5.55
Net Proceeds from Shares ⓘ	0	0	7.55	4.65	7.98	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.07	-0.07	-0.05	0.03	1.60	0.48	-0.56	-0.07	3.52	-0.55
Interest Paid ⓘ	-1.29	-1.27	-1.46	-1.44	-2	-1.45	-1.65	-1.91	-2.34	-2.71
Dividend Paid ⓘ	0	0	0	0	0	0	-0	0	0	0
Others ⓘ	0.03	2.71	7.10	1.06	-4.80	-0.70	0.03	0.34	-0.51	-2.29
Net Cash Flow ⓘ	-0.99	0.04	7.16	3.84	-7.15	-0.12	-3.53	0.87	-0.21	-0.35

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	5.65	-2.12	-2.52	-4.41	-1.23	3.09	0.18	-4.87	-12.66	5.77
ROCE (%)	7.99	0.25	-0.34	-1.38	1.48	4.58	2.44	-1.2	-6.32	8.82
Asset Turnover Ratio	0.99	0.93	0.63	0.58	0.53	0.63	0.66	0.75	0.88	1.12
PAT to CFO Conversion(x)	-1.32	N/A	N/A	N/A	N/A	2.61	-23.08	N/A	N/A	-1.26
Working Capital Days
Receivable Days	99.80	122.20	162.80	151.10	142.40	100.30	114.20	116.10	90.20	86.10
Inventory Days	124.40	147.20	190.80	181.30	211.20	188.10	184.80	162.90	151.40	128.60
Payable Days	127	165.20	231.90	221.10	234.20	200.80	190	173.80	179.90	165.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

GKB Ophthalmics Ltd FAQs

The current trading price of GKB Ophthalmics on 29-Sep-2026 16:59 is ₹64.07.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Sep-2026 the market cap of GKB Ophthalmics stood at ₹32.29 Cr

The latest P/E ratio of GKB Ophthalmics as of 28-Sep-2026 is 0.00.

The latest P/B ratio of GKB Ophthalmics as of 28-Sep-2026 is 2.34.

The 52-week high of GKB Ophthalmics is ₹76.90 and the 52-week low is ₹45.25.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of GKB Ophthalmics is ₹23.27 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that GKB Ophthalmics Ltd is a below average quality company.

The key valuation ratios of GKB Ophthalmics Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of GKB Ophthalmics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About GKB Ophthalmics Ltd

GKB Ophthalmics Limited is a public limited company domiciled in India and was incorporated on December 10, 1981 under the provisions of the Companies Act, 1956. Its registered and principal office of business is located at 16-A, Tivim Industrial Estate, Mapusa, Goa, India.

Business area of the company

The Company is engaged in the business of manufacturing and supply of semi - finished plastic lenses. It has manufacturing facilities at Tivim Industrial Estate, Mapusa - Goa.

You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

GKB Ophthalmics Ltd (GKB)

GKB Ophthalmics Ltd (GKB)

GKB Ophthalmics stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Valuation of GKB Ophthalmics - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Financials

Equity and Liabilities

Fixed Assets

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

GKB Ophthalmics Ltd FAQs

About GKB Ophthalmics Ltd

GKB Ophthalmics Ltd (GKB)

GKB Ophthalmics Ltd (GKB)

GKB Ophthalmics stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Valuation of GKB Ophthalmics - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Financials

Equity and Liabilities

Fixed Assets

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

GKB Ophthalmics Ltd FAQs

What is the share price of GKB Ophthalmics?

What is the market cap of GKB Ophthalmics?

What is the P/E ratio of GKB Ophthalmics?

What is the P/B ratio of GKB Ophthalmics?

What is the 52-week high and low of GKB Ophthalmics?

What is the TTM revenue of GKB Ophthalmics?

Is GKB Ophthalmics Ltd a good quality company?

Is GKB Ophthalmics Ltd undervalued or overvalued?

Is GKB Ophthalmics Ltd a good buy now?

About GKB Ophthalmics Ltd